Professor Peter Goadsby MBBS MD PhD DSc FRACP FRCP

My major research interests are in the basic mechanisms of primary headache disorders, such as migraine and cluster headache, in both experimental and clinical settings, and translating these insights into their better management.

I am the Director of the National Institute for Health Research - Wellcome Trust King’s Clinical Research Facility (CRF). The CRF provides dedicated facilities to support the delivery of externally-funded early translational, experimental medical research, including early-phase studies and early translational research studies that are nested within later-phase studies.

I lead the Biomedical Research Council Themes; Clinical Research Facility, and Pain and Headache. I am also the National Lead for Neurological Disorders for the Clinical Research Network, NIHR UK, a Trustee of the Organisation for the Understanding of Cluster Headache (OUCH UK) and Chair of the Scientific Programme Committee, Migraine Trust International Symposium. I also lead the Pain and Addictions theme at the NIHR Maudsley Biomedical Research Centre.

Please see my Research Staff Profile for more detail.

Key publications:

• Goadsby et al., 1990 Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Annals of Neurology. 
• May et al., 1999 Correlation between structural and functional changes in brain in an idiopathic headache syndrome. Nature Medicine.
• Goadsby et al., 2017 A controlled trial of erenumab for episodic migraine. New England Journal of Medicine.

 

Key collaborators:

• Dr Philip Holland, King's College London
• Dr Jan Hoffmann, King's College London
• Professor Steve Williams, King's College London
• Dr Fernando Zelaya, King's College London